Special Issue "Marine Antiviral Agents"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (10 August 2020).
Interests: phycology; marine molecules; extraction eco-friendly processes; antiviral agents; SAR studies
Special Issues and Collections in MDPI journals
Special Issue in Marine Drugs: Invertebrate or Macroalgae-Associated Microbiome: A New Source of Bioactive Compounds with Therapeutical, Biotechnological Applications
Special Issue in Marine Drugs: Pharmacological Models and Assays in Marine Drugs Evaluation
Despite the considerable progress made in recent years in virology, infectious human, animal, and plant viral diseases remain as worldwide problem. Effective controls and the treatments available for many infectious diseases are limited, and the need for new drugs is demonstrated, due to the increasing emergence of resistance to these available treatments. Viral infections of cultivated organisms severely disrupt the aquaculture sector. Knowledge of how to control viruses affecting aquaculture is scarce. The use and application of chemicals and antibiotics and their residual effects remain problematic.
Marine organisms (bacteria, fungi, seaweeds, invertebrates, etc.) represent a rich source of chemical diversity for the screening and identification of new compounds with antiviral properties. This Special Issue focuses on new information from present research on marine natural and synthetic compounds with antiviral potentials. Special attention will be paid to innovative track explorations, the development of new biotechnology in aquaculture, the development of innovative antiviral probiotics, eco-friendly processes of extraction and purification, the relationship between structure and activity, and the synthesis of new marine antiviral compounds.
Prof. Nathalie Bourgougnon
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Marine compounds
- Natural products
- Marine biotechnology